BMI KOREA
VC Fund
Jeju, South Korea
BMI KOREA is a VC fund in Jeju focused on Medical and Biotechnology. BMI KOREA engages in the production of pharmaceutical products and medical devices.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries BMI KOREA invests in
Stages BMI KOREA invests in
Countries BMI KOREA invests in
Investment Focus
Industry
- Medical 3 (100%)
- Biotechnology 2 (67%)
- Pharmaceutical 2 (67%)
- Health Care 1 (33%)
- Therapeutics 1 (33%)
Stage
- Series B 2 (67%)
- Seed 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
CrossPoint Therapeutics is a therapeutics company that specializes in drug development by using Stealth-Body with antibody source technology. | $2.5M / Seed / Mar 04, 2026 | |
|
|
Mito Immune Therapeutics is a drug research and development biotech company. | $3.9M / Series B / Sep 21, 2023 | |
|
|
MetaFines is a biopharma firm that creates anticancer medications with the goal of preventing the spread of cancer. By extending and reconfiguring the indications of off-label medications for terminal tumors, the company creates minimal anticancer pharmaceuticals. It also provides subcutaneous injections and therapies, allowing patients to fightcancer and enhance their standard of living with cancer metabolism.The company develops ow-toxic medicines for metabolic cancer. This low-toxic metabolic anti-cancer agent is distinguished by being created so that metabolic anti-cancer agents that limit cell growth but operate via various pathways can work in concert with one another. | $15.7M / Series B / Apr 28, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does BMI KOREA invest in?
BMI KOREA invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Series B and Seed stage. Most of the 3 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did BMI KOREA last invest?
The most recent investment recorded for BMI KOREA closed in Mar 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!